Japan’s stock market has fallen recently, with both the Nikkei 225 index and the broader TOPIX index falling, as easing domestic inflation led to speculation about future interest rate decisions by the Bank of Japan. In this context, identifying high-growth tech stocks leverages innovation and market demand to drive growth and effectively navigate these economic conditions despite broader market challenges. This includes finding companies that can.
Top 10 high-growth technology companies in Japan
name
increase in revenue
revenue growth
growth assessment
material group
20.45%
24.01%
★★★★★
hot link
50.99%
61.55%
★★★★★
eWeLL Co., Ltd.
26.52%
27.53%
★★★★★
medley
24.98%
30.36%
★★★★★
f code
22.70%
22.62%
★★★★★☆
Bengo4.com Co., Ltd.
20.76%
46.76%
★★★★★
Kanamic Network Co., Ltd.
20.75%
28.25%
★★★★★
Mental Health Technologies Co., Ltd.
27.88%
79.61%
★★★★★
exercise wizards
21.96%
75.16%
★★★★★
money forward
21.22%
71.29%
★★★★★
Click here to see the complete list of 119 Japanese High Growth Technology Stocks and AI Stock Screener.
Let’s consider some standout options from the screener results.
Simply Wall Street Growth Rating: ★★★★★☆
Overview: Finatext Holdings Ltd. operates in Japan with a focus on fintech solutions, big data analysis, and financial infrastructure businesses, and has a market capitalization of 49.08 billion yen.
Business details: The company’s revenue is mainly 3.43 billion yen from the financial infrastructure business, 1.42 billion yen from the big data analysis business, and 1.22 billion yen from the fintech solutions business.
Finatext Holdings has emerged as a notable contender in Japan’s technology space, highlighted by impressive annual revenue growth estimates of 26.2% and profit growth of 63.4%. The company’s recent return to profitability, despite facing challenges such as share price volatility and shareholder dilution over the past year, highlights the company’s potential resilience and adaptability in a competitive market. I’m doing it. Notably, Finatext invests heavily in research and development to innovate and stay competitive with industry giants. However, specific numbers for research and development expenses have not been disclosed. As it stands, whether the company can maintain this momentum could be critical to its future position in the high-growth technology sector.
TSE:4419 Revenue and Revenue Growth as of October 2024
Simply Wall Street Growth Rating: ★★★★☆
Overview: Takara Bio Inc. and its subsidiaries operate in the biotechnology, contract development and manufacturing organizations (CDMO), and gene therapy fields in Japan, China, other Asian countries, the United States, Europe, and other international markets. Masu. The market capitalization is 128.24 billion yen.
story continues
Business Description: The company primarily generates revenue from its drug discovery business, with revenue reaching 42.82 billion yen. The company operates in multiple regions including Japan, China, and the United States.
Despite overcoming a difficult year with a 99.1% decline in profits, Takara Bio is forecasting an impressive 5.6% increase in annual sales, higher than the Japanese market average of 4.2%. Despite these hurdles, the company forecasts solid earnings growth of 30.2% for the year, demonstrating strong recovery potential and resilience in the biotech sector. R&D investment remains extremely important as Takara Bio seeks to innovate in its field. However, recent updates do not reveal specific spending amounts. With recent guidance projecting full-year sales of 48.9 billion yen and operating profit of 5 billion yen, Takara Bio is poised to leverage its scientific capabilities to effectively meet growing market demands. is being arranged.
TSE: 4974 Breakdown of revenue and expenses as of October 2024
Simply Wall Street Growth Rating: ★★★★★☆
Overview: Fujisoft Co., Ltd. is an IT company that operates domestically and internationally and boasts a market capitalization of 608.29 billion yen.
Business Description: The company primarily generates revenue from the SI business segment, which has sales of 290.11 billion yen. Facility business sales were 3.42 billion yen.
Fujisoft is in the midst of a transformational period characterized by increased digitalization and M&A activity, and is exhibiting remarkable financial dynamism. Revenue growth is ahead at 21.7% per year compared to the Japanese market’s 8.7% per year, and the company is strategically positioned within its sector, with revenue forecasts increasing modestly by 4.7% per year. Recent acquisition interest from global investment firms such as KKR highlights Fujisoft’s pivotal role in Japan’s IT services industry, with a significant takeover bid at a premium of over 97% further It’s backed up. This corporate strategy not only reflects Fujisoft’s confidence in its future prospects, but also highlights Fujisoft’s central position in an industry that is increasingly dependent on advanced technology solutions.
TSE:9749 Revenue and Revenue Growth as of October 2024
Important points
Looking for another opportunity?
This article by Simply Wall St is general in nature. We provide commentary using only unbiased methodologies, based on historical data and analyst forecasts, and articles are not intended to be financial advice. This is not a recommendation to buy or sell any stock, and does not take into account your objectives or financial situation. We aim to provide long-term, focused analysis based on fundamental data. Note that our analysis may not factor in the latest announcements or qualitative material from price-sensitive companies. Simply Wall St has no position in any stocks mentioned.
Companies featured in this article include TSE:4419 TSE:4974 and TSE:9749.
Do you have feedback on this article? Interested in its content? Please contact us directly. Alternatively, email us at editorial-team@simplywallst.com.
